Clinical trial
A Phase 1 Study of DS-1001b in Patients With IDH1 Mutated Gliomas
NCT03030066 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of DS-1001b in Patients With IDH1 Mutated Gliomas
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 19, 2017
- Completion date
- July 16, 2026
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.